Viewing nowCombinationVastin Tablets 10/20 Milligrams
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201600903 · Approved 2016.02.17 · Insurance code 657805760
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication is used as an adjunct to diet in patients with primary hypercholesterolemia to help reduce elevated total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, while increasing HDL cholesterol. Particularly in patients with homozygous familial hypercholesterolemia, it is used when other lipid-lowering treatments are not effective or used in conjunction with those treatments. This medication should be taken alongside a proper diet, and potential impacts from other conditions or medications must be confirmed beforehand. Careful consideration is required as a lipid-lowering agent for patients at high risk of cardiovascular disease. Regular blood lipid tests during treatment are important; especially in patients with acute coronary events, measuring lipid levels at the time of hospitalization or within 24 hours post-admission is recommended. Overall, this medication is used effectively to improve hypercholesterolemia and related lipid abnormalities.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medication may cause adverse reactions in muscles, so it is important to immediately inform a doctor if symptoms such as muscle pain or weakness occur. There is a serious risk of muscle damage, including myopathy and rhabdomyolysis, especially when taking high doses, so extra caution is needed. Patients with allergies to any component of this medication, active liver disease, or persistent unexplained elevations in liver enzymes should not take this medication. Women who are pregnant or nursing should not take this medication, and women of childbearing age should confirm pregnancy status before taking it. When taken with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and HIV medications, the risk of muscle damage greatly increases; therefore, co-administration should be avoided. This medication should also not be taken with gemfibrozil, cyclosporine, or danazol. Elderly patients, those with hypothyroidism, or patients with decreased kidney function have a higher risk of myopathy, so caution is necessary during use. This medication can affect liver function, so patients with liver disease should have regular liver function tests and should consult a doctor immediately if symptoms of liver function abnormalities occur. If any muscle-related symptoms or liver function abnormalities develop, the use of this medication should be discontinued and healthcare personnel should be consulted. Furthermore, this medication may interact with various drugs, so when taking new medications, it is essential to inform healthcare personnel of the use of this medication. Excessive consumption of grapefruit juice may raise the blood concentration of this medication, increasing the risk of side effects. This medication is not recommended for children or those under 10 years of age, as safety and effectiveness have not been adequately established. While taking this medication, blood sugar levels may rise, so patients at risk for diabetes should regularly monitor their blood glucose levels. There is no specific antidote for overdose, so appropriate treatment based on symptoms is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperature between 1 and 30 degrees Celsius.
White to off-white, double-convex rectangular tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.